Screener
Bio-Techne TECH EBITDA
EBITDA at other companies
Other financials
Where this comes from
Calculated from Bio-Techne’s reported figures.
The source filing: Bio-Techne’s 10-Q, filed May 6, 2026. Open the filing →
- Filed
- May 6, 2026, 4:31 PM EDT
- Fiscal quarter
- Q3 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-056302
FAQ
- What is Bio-Techne's EBITDA?
- Bio-Techne (TECH) reported EBITDA of $99.66M in Q1 2026.
- How has Bio-Techne's EBITDA changed year-over-year?
- Bio-Techne's EBITDA increased by 50.4% year-over-year, from $66.28M to $99.66M.
- What is the long-term trend for Bio-Techne's EBITDA?
- Over 2 years (2022 to 2024), Bio-Techne's EBITDA has grown at a -10.5% compound annual growth rate (CAGR), from $397.66M to $318.4M.
- What does EBITDA mean?
- Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.
Ask your AI about Bio-Techne's ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude